In the wake of the Spring Festival holiday, businesses resident in the Taizhou Medical High-tech Zone – located in Taizhou city, in East China's Jiangsu province – have restarted operations at a brisk pace, to ensure strong financial results in the first quarter.
The resumption rate of manufacturers above a designated size in the park – those with annual sales of 20 million yuan ($2.96 million) or more – has now ramped up to over 95 percent, according Shen Jin, a senior official at the Chemicals New Materials Industry Park in the zone.
In one company, staff members at Sinovet (Jiangsu) Biopharmaceuticals Co Ltd have really devoted themselves to vaccine reagents production after the holiday.
Although 2023 has just started, the R&D center of Sinovet has already developed eight products and they have been going through the clinical and registration phases, said company president Su Weiwei.
Elsewhere, all 245 employees of Taizhou Yourun Electronic Technology Co Ltd have returned to work and resumed production. The order book now runs to the end of March and 90 percent of the machines are currently running at capacity.
As a high-tech enterprise engaged in electronics products R&D and the manufacture of semiconductors integrated circuits and other products, the company now has more than 10 ranges and 100 products.
As a result, it is projected to generate invoiced sales of 800 million yuan and a tax payment of 10 million yuan in the current year.